Jim Letourneau
Jim Letourneau is the founder and editor of the Big Picture Speculator and is a geologist living in Calgary, Alberta. He is an early-stage investor in energy, metals, biotech and technology companies. He speaks at investment conferences across North America.
Recent Quotes
"ONCY's Reolysin reovirus can inject into tumors to kill cancerous cells."
—
The Life Sciences Report Interview with Jim Letourneau
(8/15/13)
more >
"VRS has an amazing, game-changing device that detects skin cancer with good accuracy."
—
The Life Sciences Report Interview with Jim Letourneau
(8/15/13)
more >
"BTI's Transcend technology allows drugs to cross the blood-brain barrier, which is a big issue for treating brain disease."
—
The Life Sciences Report Interview with Jim Letourneau
(8/15/13)
more >
"BSP has a big land position with a foot in the Wolfberry door."
—
The Energy Report Interview with Jim Letourneau
(8/8/13)
more >
"ZEX has a big land package in California's San Joaquin Basin and has farmed some of it out."
—
The Energy Report Interview with Jim Letourneau
(8/8/13)
more >
"I think everyone is expecting BSP's share value to grow."
—
The Energy Report Interview with Jim Letourneau
(4/25/13)
more >
"URE just closed a $5.1M transaction that provides upfront cash in return for future uranium deliveries."
—
The Energy Report Interview with Jim Letourneau
(4/25/13)
more >
"VRS' platform is very compelling."
—
The Life Sciences Report Interview with Jim Letourneau
(1/17/13)
more >
